Price T Rowe Associates Inc Gilead Sciences, Inc. Transaction History

Price T Rowe Associates Inc

  • $836 Billion
  • Q2 2024

A detailed history of Price T Rowe Associates Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,845,428 shares of GILD stock, worth $238 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,845,428
Previous 2,492,514 14.16%
Holding current value
$238 Million
Previous $183 Million 6.93%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$63.15 - $72.88 $22.3 Million - $25.7 Million
352,914 Added 14.16%
2,845,428 $195 Million
Q1 2024

May 15, 2024
SELL
$71.58 - $87.29 $23.5 Million - $28.7 Million
-328,986 Reduced 11.66%
2,492,514 $183 Million
Q4 2023

Feb 14, 2024
BUY
$73.27 - $83.09 $40.4 Million - $45.8 Million
550,974 Added 24.27%
2,821,500 $229 Million
Q3 2023

Nov 14, 2023
SELL
$73.94 - $80.67 $62.9 Million - $68.7 Million
-851,119 Reduced 27.27%
2,270,526 $170 Million
Q2 2023

Aug 14, 2023
BUY
$76.01 - $86.7 $49 Million - $55.9 Million
644,251 Added 26.01%
3,121,645 $241 Million
Q1 2023

May 15, 2023
BUY
$77.31 - $88.08 $5.21 Million - $5.93 Million
67,356 Added 2.79%
2,477,394 $206 Million
Q4 2022

Feb 14, 2023
BUY
$62.32 - $89.47 $47.2 Million - $67.7 Million
756,984 Added 45.79%
2,410,038 $207 Million
Q3 2022

Nov 14, 2022
SELL
$59.54 - $68.01 $24.1 Million - $27.5 Million
-404,237 Reduced 19.65%
1,653,054 $102 Million
Q2 2022

Aug 15, 2022
SELL
$57.72 - $65.01 $25.7 Million - $28.9 Million
-444,414 Reduced 17.76%
2,057,291 $127 Million
Q1 2022

May 16, 2022
SELL
$57.92 - $72.58 $13.2 Million - $16.6 Million
-228,171 Reduced 8.36%
2,501,705 $149 Million
Q4 2021

Feb 14, 2022
SELL
$64.88 - $73.64 $55.5 Million - $63 Million
-854,995 Reduced 23.85%
2,729,876 $198 Million
Q3 2021

Nov 15, 2021
SELL
$67.69 - $73.03 $112 Million - $120 Million
-1,649,613 Reduced 31.51%
3,584,871 $250 Million
Q2 2021

Aug 16, 2021
SELL
$63.47 - $69.35 $11 Million - $12 Million
-173,266 Reduced 3.2%
5,234,484 $360 Million
Q1 2021

May 17, 2021
SELL
$60.0 - $68.46 $60.2 Million - $68.7 Million
-1,003,010 Reduced 15.65%
5,407,750 $350 Million
Q4 2020

Feb 16, 2021
BUY
$56.65 - $64.55 $363 Million - $414 Million
6,410,760 New
6,410,760 $373 Million

Others Institutions Holding GILD

# of Institutions
1,879
Shares Held
1.02B
Call Options Held
12M
Put Options Held
8.96M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email